Bayer AG, maker of the antibleeding drug Trasylol, has announced that worldwide sales of the drug will be brought to a halt due to a clinical study linking Trasylol with a higher risk of death.
Read Full Article Here
Global Sales of Trasylol Are Stopped
October 16, 2015 by
